Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient
NCT03132493
·
clinicaltrials.gov ↗
COMPLETED
Status
676
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG:
Nivolumab 10 MG/ML
Sponsor
Spanish Lung Cancer Group